The DOI matches its Crossref record; 209 of the 209 references it cites were found in a registry or an index.
Risk factors for amyotrophic lateral sclerosis
Open accessAbstract
Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease. It is typically fatal within 2-5 years of symptom onset. The incidence of ALS is largely uniform across most parts of the world, but an increasing ALS incidence during the last decades has been suggested. Although recent genetic studies have substantially improved our understanding of the causes of ALS, especially familial ALS, an important role of non-genetic factors in ALS is recognized and needs further study. In this review, we briefly discuss several major genetic contributors to ALS identified to date, followed by a more focused discussion on the most commonly examined non-genetic risk factors for ALS. We first review factors related to lifestyle choices, including smoking, intake of antioxidants, physical fitness, body mass index, and physical exercise, followed by factors related to occupational and environmental exposures, including electromagnetic fields, metals, pesticides, β-methylamino-L-alanine, and viral infection. Potential links between ALS and other medical conditions, including head trauma, metabolic diseases, cancer, and inflammatory diseases, are also discussed. Finally, we outline several future directions aiming to more efficiently examine the role of non-genetic risk factors in ALS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P. H., Albert, M., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1546 · Cited by 5,047
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
Sreedharan, J., Blair, I. P., Tripathi, V. B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J. C., Williams, K. L., Buratti, E., et al. (2008) · Science · doi:10.1126/science.1154584 · Cited by 2,630
A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
Bensimon, G., Lacomblez, L., & Meininger, V. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300901 · Cited by 2,233
State of play in amyotrophic lateral sclerosis genetics
Renton, A. E., Chiò, A., & Traynor, B. J. (2014) · Nature Neuroscience · doi:10.1038/nn.3584 · Cited by 1,544
TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis
Kabashi, E., Valdmanis, P. N., Dion, P., Spiegelman, D., McConkey, B. J., Velde, C. V., Bouchard, J.-P., Lacomblez, L., Pochigaeva, K., Salachas, F., et al. (2008) · Nature Genetics · doi:10.1038/ng.132 · Cited by 1,544
Dose-ranging study of riluzole in amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis/Riluzole Study Group II, Lacomblez, L., Bensimon, G., Meininger, V, Leigh, P. N., & Guillet, P. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91680-3 · Cited by 1,301
Cited by
Role of neuroinflammation in neurodegeneration development
Zhang, W., Xiao, D., Mao, Q., & Xia, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01486-5 · Cited by 1,668
“, mutations in SOD1, C9orf72, and TDP-43) and environmental factors.(80) TDP-43 aggregates, the primary pathogenic factor of ALS, can invade mitochondria, release mtDNA into the cytosol, and induce inflammation in neurons through activating cGAS/STING pathway.”
BackgroundDose-ranging study of riluzole in amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis/Riluzole Study Group II, Lacomblez, L., Bensimon, G., Meininger, V, Leigh, P. N., & Guillet, P. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91680-3 · Cited by 1,301
Amyotrophic lateral sclerosis: a clinical review
Masrori, P., & Van Damme, P. (2020) · European Journal of Neurology · doi:10.1111/ene.14393 · Cited by 1,201
Inflammation in CNS neurodegenerative diseases
Stephenson, J., Nutma, E., van der Valk, P., & Amor, S. (2018) · Immunology · doi:10.1111/imm.12922 · Cited by 966
Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications
Liu, Z., Zhou, T., Ziegler, A. C., Dimitrion, P., & Zuo, L. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/2525967 · Cited by 810
Epidemiology of amyotrophic lateral sclerosis: an update of recent literature
Longinetti, E., & Fang, F. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000730 · Cited by 620
Self-citationEpidemiology of mutations in superoxide dismutase in amyotrophic lateal sclerosis
Cudkowicz, M. E., McKenna‐Yasek, D., Sapp, P. E., Chin, W., Geller, B., Hayden, D. L., Schoenfeld, D. A., Hosler, B. A., Horvitz, H. R., & Brown, R. H. (1997) · Annals of Neurology · doi:10.1002/ana.410410212 · Cited by 533
Mead, R. J., Shan, N., Reiser, H. J., Marshall, F., & Shaw, P. J. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00612-2 · Cited by 505
Leigh, P. N., & Ray-Chaudhuri, K. (1994) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.8.886 · Cited by 331
Onset, natural history and outcome in idiopathic adult motor neuron disease
Norris, F., Shepherd, R., Denys, E., U, K., Mukai, E., Elias, L., Holden, D., & Norris, H. (1993) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(93)90245-t · Cited by 302
The value of muscle exercise in patients with amyotrophic lateral sclerosis
Drory, V. E., Goltsman, E., Goldman Reznik, J., Mosek, A., & Korczyn, A. D. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00610-4 · Cited by 283
Organophosphate pesticide exposure and neurodegeneration
Sánchez-Santed, F., Colomina, M. T., & Herrero Hernández, E. (2016) · Cortex · doi:10.1016/j.cortex.2015.10.003 · Cited by 257
The multistep hypothesis of ALS revisited: The role of genetic mutations
Chiò, A., Mazzini, L., D'Alfonso, S., Corrado, L., Canosa, A., Moglia, C., Manera, U., Bersano, E., Brunetti, M., Barberis, M., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000005996 · Cited by 212
Dendritic Spine Pathology in Neurodegenerative Diseases
Herms, J., & Dorostkar, M. M. (2016) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044216 · Cited by 201
Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease
Dal Bello-Haas, V., & Florence, J. M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005229.pub3 · Cited by 178
The Complex Molecular Biology of Amyotrophic Lateral Sclerosis (ALS)
Redler, R. L., & Dokholyan, N. V. (2012) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-385883-2.00002-3 · Cited by 172
Traumatic injury induces stress granule formation and enhances motor dysfunctions in ALS/FTD models
Anderson, E. N., Gochenaur, L., Singh, A., Grant, R., Patel, K., Watkins, S., Wu, J. Y., & Pandey, U. B. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy047 · Cited by 96
Body Mass Index and Amyotrophic Lateral Sclerosis: A Study of US Military Veterans
Mariosa, D., Beard, J. D., Umbach, D. M., Bellocco, R., Keller, J., Peters, T. L., Allen, K. D., Ye, W., Sandler, D. P., Schmidt, S., et al. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kww140 · Cited by 67
Self-citationFilippini, T., Fiore, M., Tesauro, M., Malagoli, C., Consonni, M., Violi, F., Arcolin, E., Iacuzio, L., Oliveri Conti, G., Cristaldi, A., et al. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17030857 · Cited by 62
Kurland, L. T., Radhakrishnan, K., Smith, G. E., Armon, C., & Nemetz, P. N. (1992) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(92)90241-c · Cited by 48
Lian, L., Liu, M., Cui, L., Guan, Y., Liu, T., Cui, B., Zhang, K., Tai, H., & Shen, D. (2019) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2019.05.036 · Cited by 47
Head Injury and Amyotrophic Lateral Sclerosis: A Meta-Analysis
Liu, G., Ou, S., Cui, H., Li, X., Yin, Z., Gu, D., & Wang, Z. (2021) · Neuroepidemiology · doi:10.1159/000510987 · Cited by 41
Gut microbiome and amyotrophic lateral sclerosis: a systematic review of current evidence
Sun, J., Huang, T., Debelius, J. W., & Fang, F. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13336 · Cited by 43
Self-citationAntidiabetics, statins and the risk of amyotrophic lateral sclerosis
Mariosa, D., Kamel, F., Bellocco, R., Ronnevi, L. ‐., Almqvist, C., Larsson, H., Ye, W., & Fang, F. (2020) · European Journal of Neurology · doi:10.1111/ene.14190 · Cited by 38
Self-citationNutrient effects on motor neurons and the risk of amyotrophic lateral sclerosis
Goncharova, P. S., Davydova, T. K., Popova, T. E., Novitsky, M. A., Petrova, M. M., Gavrilyuk, O. A., Al-Zamil, M., Zhukova, N. G., Nasyrova, R. F., & Shnayder, N. A. (2021) · Nutrients · doi:10.3390/nu13113804 · Cited by 35
Pramoda, G., Verma, R. K., Kesharwani, P., & Shukla, R. (2025) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2025.127938 · Cited by 15
Chourpiliadis, C., Seitz, C., Lovik, A., Joyce, E. E., Pan, L., Hu, Y., Kläppe, U., Samuelsson, K., Press, R., Ingre, C., et al. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12496-w · Cited by 10
“Many environmental risk factors have been studied in relation to ALS [9, 10], with some of the associations potentially varying by age, sex, and genetic factors [11–15].”
BackgroundSelf-citationPre-Morbid Risk Factors for Amyotrophic Lateral Sclerosis: Prospective Cohort Study
Batty, G. D., & Gale, C. R. (2021) · Clinical Epidemiology · doi:10.2147/clep.s329521 · Cited by 5
Mitsi, E., Christodoulou, C. C., Nicolaou, P., Christodoulou, K., & Zamba-Papanicolaou, E. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1264743 · Cited by 5
Head Injury and Amyotrophic Lateral Sclerosis: Population-Based Study from the National ALS Registry
Raymond, J., Howard, I. M., Berry, J., Larson, T., Horton, D. K., & Mehta, P. (2025) · Brain Sciences · doi:10.3390/brainsci15020143 · Cited by 4
Metadata
- Authors
- Fang, F., Ingre, C., Roos, P., Kamel, F., & Piehl, F.
- Venue
- Clinical Epidemiology
- Publisher
- Informa UK Limited
- Published
- 2015-02
- Volume
- 7
- Pages
- 181
- ISSN
- 1179-1349 (ISSN-L)
- OpenAlex
- W2081394676
- Cited by
- 462
- References
- 209
- FWCI
- 24.90
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.